DK0789716T3 - Antistoffer mod allogene og xenogene proteiner, deres anvendelse ved diagnose og terapi og fremgangsmåder til bestemmelse h - Google Patents

Antistoffer mod allogene og xenogene proteiner, deres anvendelse ved diagnose og terapi og fremgangsmåder til bestemmelse h

Info

Publication number: DK0789716T3
Authority: DK; Denmark
Prior art keywords: allogeneic; antibodies; diagnosis; therapy; determining
Prior art date: 1994-11-04

Application number

DK95936566T

Other languages

English (en)

Inventor

Alberto Bartorelli

Original Assignee

Zetesis Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-11-04

Filing date

1995-10-30

Publication date

2000-10-09

1995-10-30 Application filed by Zetesis Spa filed Critical Zetesis Spa

2000-10-09 Application granted granted Critical

2000-10-09 Publication of DK0789716T3 publication Critical patent/DK0789716T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Mycology (AREA)
Analytical Chemistry (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Bioinformatics & Cheminformatics (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK95936566T 1994-11-04 1995-10-30 Antistoffer mod allogene og xenogene proteiner, deres anvendelse ved diagnose og terapi og fremgangsmåder til bestemmelse h DK0789716T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT94MI002238A IT1276860B1 (it)	1994-11-04	1994-11-04	Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione
PCT/EP1995/004239 WO1996014340A1 (en)	1994-11-04	1995-10-30	Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof

Publications (1)

Publication Number	Publication Date
DK0789716T3 true DK0789716T3 (da)	2000-10-09

Family

ID=11369803

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95936566T DK0789716T3 (da)	1994-11-04	1995-10-30	Antistoffer mod allogene og xenogene proteiner, deres anvendelse ved diagnose og terapi og fremgangsmåder til bestemmelse h

Country Status (26)

Country	Link
EP (1)	EP0789716B1 (da)
JP (1)	JPH10508591A (da)
KR (1)	KR100426029B1 (da)
CN (1)	CN1046737C (da)
AR (1)	AR002243A1 (da)
AT (1)	ATE192166T1 (da)
AU (1)	AU690756B2 (da)
BR (1)	BR9509556A (da)
CA (1)	CA2204380A1 (da)
CZ (1)	CZ288322B6 (da)
DE (1)	DE69516534T2 (da)
DK (1)	DK0789716T3 (da)
ES (1)	ES2147617T3 (da)
FI (1)	FI971879L (da)
GR (1)	GR3033956T3 (da)
HU (1)	HUT76880A (da)
IL (1)	IL115862A (da)
IT (1)	IT1276860B1 (da)
NO (1)	NO972046L (da)
NZ (1)	NZ295171A (da)
PL (1)	PL181115B1 (da)
PT (1)	PT789716E (da)
RU (1)	RU2160445C2 (da)
TR (1)	TR199501353A2 (da)
WO (1)	WO1996014340A1 (da)
ZA (1)	ZA959255B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1283634B1 (it) *	1996-05-10	1998-04-23	Zetesis Spa	Un metodo citofluorimetrico per la determinazione nel siero di anti- corpi anti-antigene tumorali
US20010014471A1 (en) *	1999-04-15	2001-08-16	Vytautas Naktinis	Recombinant protein and its use in therapy and diagnostics
IT201600127428A1 (it) *	2016-12-16	2018-06-16	Cusani Alberto Bartorelli	Nuova proteina ricombinante uk 114 in forma stabile polimerica per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne
IT201900022203A1 (it) *	2019-11-26	2021-05-26	Cusani Alberto Bartorelli	Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1244879B (it) *	1990-12-11	1994-09-12	Alberto Bartorelli	Estratti da tessuti animali, utili in terapia e in diagnostica.

1994
- 1994-11-04 IT IT94MI002238A patent/IT1276860B1/it active IP Right Grant
1995
- 1995-10-30 ES ES95936566T patent/ES2147617T3/es not_active Expired - Lifetime
- 1995-10-30 WO PCT/EP1995/004239 patent/WO1996014340A1/en active IP Right Grant
- 1995-10-30 EP EP95936566A patent/EP0789716B1/en not_active Expired - Lifetime
- 1995-10-30 AU AU38453/95A patent/AU690756B2/en not_active Ceased
- 1995-10-30 DK DK95936566T patent/DK0789716T3/da active
- 1995-10-30 NZ NZ295171A patent/NZ295171A/en unknown
- 1995-10-30 CA CA002204380A patent/CA2204380A1/en not_active Abandoned
- 1995-10-30 HU HU9701505A patent/HUT76880A/hu unknown
- 1995-10-30 CZ CZ19971314A patent/CZ288322B6/cs not_active IP Right Cessation
- 1995-10-30 RU RU97108978/14A patent/RU2160445C2/ru not_active IP Right Cessation
- 1995-10-30 PL PL95319878A patent/PL181115B1/pl not_active IP Right Cessation
- 1995-10-30 CN CN95195990A patent/CN1046737C/zh not_active Expired - Fee Related
- 1995-10-30 BR BR9509556A patent/BR9509556A/pt not_active Application Discontinuation
- 1995-10-30 JP JP8515018A patent/JPH10508591A/ja not_active Ceased
- 1995-10-30 KR KR1019970702940A patent/KR100426029B1/ko not_active Expired - Fee Related
- 1995-10-30 AT AT95936566T patent/ATE192166T1/de not_active IP Right Cessation
- 1995-10-30 PT PT95936566T patent/PT789716E/pt unknown
- 1995-10-30 DE DE69516534T patent/DE69516534T2/de not_active Expired - Fee Related
- 1995-11-02 TR TR95/01353A patent/TR199501353A2/xx unknown
- 1995-11-02 AR ARP950100034A patent/AR002243A1/es unknown
- 1995-11-02 ZA ZA959255A patent/ZA959255B/xx unknown
- 1995-11-02 IL IL11586295A patent/IL115862A/en active IP Right Grant
1997
- 1997-05-02 NO NO972046A patent/NO972046L/no not_active Application Discontinuation
- 1997-05-02 FI FI971879A patent/FI971879L/fi unknown
2000
- 2000-07-14 GR GR20000401641T patent/GR3033956T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN1046737C (zh)	1999-11-24
PL181115B1 (pl)	2001-05-31
NO972046D0 (no)	1997-05-02
CN1166838A (zh)	1997-12-03
PL319878A1 (en)	1997-09-01
FI971879L (fi)	1997-06-24
NZ295171A (en)	1998-07-28
BR9509556A (pt)	1997-09-16
ITMI942238A1 (it)	1996-05-04
CZ288322B6 (en)	2001-05-16
ES2147617T3 (es)	2000-09-16
EP0789716A1 (en)	1997-08-20
EP0789716B1 (en)	2000-04-26
AU3845395A (en)	1996-05-31
JPH10508591A (ja)	1998-08-25
ZA959255B (en)	1996-05-29
DE69516534T2 (de)	2000-11-30
MX9703191A (es)	1997-07-31
GR3033956T3 (en)	2000-11-30
CA2204380A1 (en)	1996-05-17
KR970707161A (ko)	1997-12-01
DE69516534D1 (de)	2000-05-31
NO972046L (no)	1997-05-02
IT1276860B1 (it)	1997-11-03
ITMI942238A0 (it)	1994-11-04
PT789716E (pt)	2000-09-29
RU2160445C2 (ru)	2000-12-10
IL115862A (en)	2001-06-14
WO1996014340A1 (en)	1996-05-17
IL115862A0 (en)	1996-01-31
CZ131497A3 (en)	1997-12-17
AR002243A1 (es)	1998-03-11
HUT76880A (en)	1997-12-29
FI971879A0 (fi)	1997-05-02
KR100426029B1 (ko)	2004-07-31
ATE192166T1 (de)	2000-05-15
TR199501353A2 (tr)	1996-06-21
AU690756B2 (en)	1998-04-30

Publication	Publication Date	Title
NO973447L (no)	1997-09-26	Monoklonale antistoffer som er spesifikke for forskjellige epitoper i human-gp 39, og fremgangsmåter for deres anvendelse i diagnose og terapi
EE04377B1 (et)	2004-10-15	Kehakaalu modulaatorid, neile vastavad nukleiinhapped ja valgud ning nende kasutamine diagnostikas ja teraapias
DE69429877D1 (de)	2002-03-21	Blutströmungsmessmethode in hämodialyseweiche
DK1818343T3 (da)	2012-07-16	Antistoffer mod humant IL-12
DK40484A (da)	1984-08-01	Polysaccharid/protein-konjugat, fremgangsmaade til fremstilling deraf og dets anvendelse i en vaccine
FI963101L (fi)	1996-08-06	Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut
DE69529245D1 (de)	2003-02-06	Nicht-invasiver Blutanalysator
DE69531345D1 (de)	2003-08-28	Rekombinant pgp3, verfahren zu dessen herstellung, und dessen verwendung in der diagnose und therapie
FR2766192B1 (fr)	2001-07-13	Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
DK1012181T3 (da)	2007-01-02	Overfladeantigener og proteiner, der er nyttige i præparater til diagnose og forebyggelse af Lymes sygdom
DE68917273D1 (de)	1994-09-08	Testmethode und Gerät zur Bestimmung des gesamten Proteins.
DK0789716T3 (da)	2000-10-09	Antistoffer mod allogene og xenogene proteiner, deres anvendelse ved diagnose og terapi og fremgangsmåder til bestemmelse h
NO872881D0 (no)	1987-07-10	Fremgangsmaate for bestemmelse av skjult blad i proever fra mennesker.
FI964227L (fi)	1996-10-21	Hepariinia sitova proteiini verenmyrkytyksen hoitoon ja menetelmät sen valmistamiseksi
DK482989D0 (da)	1989-10-02	Apparat til brug ved ultralydundersoegelse
IT1279079B1 (it)	1997-12-04	Vibratore,in particolare per laboratorio dentistico
EP0269677A4 (en)	1990-03-08	ANALYZES AND ANTIBODIES OF N - i PROTEINS (myc).
FI972055L (fi)	1997-05-14	Syljen analysointimenetelmä
DE69735760D1 (de)	2006-06-01	Antikörper gegen menschliches lect2, zellen die diesen produzieren und verfahren und kit zu dessen bestimmung
NO980252D0 (no)	1998-01-20	In vivo diabetes-test
IT1285523B1 (it)	1998-06-08	Laccasi modificata metodo per la sua preparazione e suo impiego nel settore alimentare
NO903222D0 (no)	1990-07-18	Diagnostiske maalinger og deres anvendelse ved bestemmelseav kliniske tilstander.
ITBO970413A0 (it)	1997-07-07	Metodo per l'esame antropometrico della complessione facciale in ortog natodonzia.
ITRM920717A0 (it)	1992-09-30	Corredo diagnostico immunologico e metodo per la sua utilizzazione.
SE9503044D0 (sv)	1995-09-05	Antibodies for use in cancer therapy and diagnosis